Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions
Authors:
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 98 (9) , 3373-3386
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Characterization of amorphous API:Polymer mixtures using X-ray powder diffractionJournal of Pharmaceutical Sciences, 2008
- Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solidsJournal of Pharmaceutical Sciences, 2006
- Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility APIPharmaceutical Research, 2006
- Amorphous Drug Delivery Systems: Molecular Aspects, Design, and PerformanceCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Powder diffraction: Least-squares and beyondJournal of Research of the National Institute of Standards and Technology, 2004
- What is the True Solubility Advantage for Amorphous Pharmaceuticals?Pharmaceutical Research, 2000
- Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitatesJournal of Pharmaceutical Sciences, 1995
- Use of Full Diffraction Spectra, Both Experimental and Calculated, in Quantitative Powder Diffraction AnalysisAustralian Journal of Physics, 1988
- X-Ray DiffractionPhysics Today, 1970
- Smoothing and Differentiation of Data by Simplified Least Squares Procedures.Analytical Chemistry, 1964